Skip to content
OpenCapital
Get started

Atai Life Sciences ATAI Q3 2025 earnings

Reported November 12, 2025 · Before market open

Revenue$749.0KBeat by $519.8K
EPS-$0.28Miss by $0.16
Revenue estimate$229.2K
EPS estimate-$0.12

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$111.1K
EPS estimate-$0.10

Versus estimates

Revenue

Q1 2026$954.0KBeat by $736.9KQ4 2025$1.1MBeat by $766.0K
Q3 2025$749.0KBeat by $519.8K
Q2 2025$719.0KQ1 2025$1.6MQ4 2024-$5.0KMiss by $305.0K

Diluted EPS

Q1 2026-$0.08Beat by $0.03Q4 2025-$0.05Beat by $0.07
Q3 2025-$0.28Miss by $0.16
Q2 2025-$0.14Miss by $0.02Q1 2025-$0.15Beat by $0.04Q4 2024-$0.24Miss by $0.10

Ask the moment Atai Life Sciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Atai Life Sciences report Q3 2025 earnings?
Atai Life Sciences (ATAI) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Atai Life Sciences 's Q3 2025 revenue and EPS?
Atai Life Sciences reported revenue of $749.0K and eps of $-0.28 for Q3 2025.
Did Atai Life Sciences beat estimates in Q3 2025?
Revenue beat the consensus estimate of $229.2K by $519.8K. EPS missed the consensus estimate of $-0.12 by $0.16.
How did Atai Life Sciences 's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1772.5% from $40.0K a year earlier and eps declined 75.0% from $-0.16.
Where can I find Atai Life Sciences 's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001140361-25-041546) and the 10-Q periodic report (0001193125-25-277583) directly on SEC EDGAR. The filing index links above go to sec.gov.